You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
邁瑞醫療(300760.SZ):接下來將積極參與國內組織的超聲刀、腔鏡吻合器等產品的集採
格隆匯 07-30 08:48

格隆匯7月30日丨邁瑞醫療(300760.SZ)近日接受特定對象調研時表示,隨着4K+熒光和4K+3D胸腹腔硬鏡系統,以及圍繞胸腹腔手術所需要的電刀、超聲刀、能量平台、腔鏡吻合器等配套器械和耗材的上市,公司已經基本完成了胸腹腔微創外科手術的產品佈局,並且產品競爭力已經達到了國內領先水平。

以今年上市的智能腔鏡吻合器為例,傷口吻合是手術過程中的一個高風險程序,因此產品的安全性能是關鍵。通過產品內置的芯片和智能化算法,針對不同組織特性主動調節擊發速度,從而有效規避極端情況的風險,使得邁瑞吻合器的成釘良率超過98%,和進口品牌的成釘良率水平一致。接下來,公司將積極參與國內組織的超聲刀、腔鏡吻合器等產品的集採,以期實現產品的快速放量。

雖然胸腹腔外科手術量佔比較大,但微創外科是一個很大的範疇,未來公司在迭代升級胸腹腔外科產品的同時,將進入更多新的微創外科領域,並且有節奏地探索手術機器人業務,為公司長期的快速發展培育新的增長極。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account